-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WiGNWDWbMzSBrQZSNBpxH+qllfTdwo6WgxZNhu4QN4vKN/4NDRwJ/3vQUARrpawy c092NanB0I3R9DmzIKdD3w== 0001332432-05-000027.txt : 20050908 0001332432-05-000027.hdr.sgml : 20050908 20050908195530 ACCESSION NUMBER: 0001332432-05-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050906 FILED AS OF DATE: 20050908 DATE AS OF CHANGE: 20050908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rubinstein Linda M CENTRAL INDEX KEY: 0001321937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 051076383 BUSINESS ADDRESS: BUSINESS PHONE: (510) 670-9300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-09-06 0000913275 Solexa, Inc. SLXA 0001321937 Rubinstein Linda M C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 VP & Chief Financial Officer Employee Stock Option (right to buy) 5.97 2005-09-06 4 A 0 25000 5.97 A 2015-09-06 Common Stock 25000 25000 D Shares will vest monthly from the vesting commencement date, September 6, 2005, over a four year period. Upon the consummation of an Asset Sale, Merger, Consolidation or Reverse Merger, each as defined in the Company's 2005 Equity Incentive Plan, the vesting and exercisability of the option shall be accelerated two (2) years. /s/ Linda Rubinstein 2005-09-07 -----END PRIVACY-ENHANCED MESSAGE-----